Research programme: neurodegenerative disease therapeutics and diagnostics - Neuro-Bio

Drug Profile

Research programme: neurodegenerative disease therapeutics and diagnostics - Neuro-Bio

Alternative Names: NBP-14

Latest Information Update: 10 May 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Neuro-Bio
  • Class Antidementias; Calcium regulators; Neuropeptides
  • Mechanism of Action Acetylcholinesterase replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes
  • Available For Licensing Yes - Alzheimer's disease

Highest Development Phases

  • Preclinical Alzheimer's disease
  • Research Neurodegenerative disorders

Most Recent Events

  • 04 May 2017 Early research in Neurodegenerative disorders in United Kingdom before May 2017 (unspecified route)
  • 22 Mar 2017 Neurodegenerative disease therapeutics and diagnostics - Neuro-Bio is available for licensing as of 01 May 2016.
  • 25 May 2016 Neuro-Bio intends to initiate phase I trials in 2017 (Neuro-Bio website, May 2016)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top